American Urological Association Annual Meeting

Apalutamide Induces Impressive PSA Response and Solid Adherence Rates in Men with nmCRPC

September 23, 2021

Real-world evidence recently presented at the 2021 AUA Annual Meeting showed that high adherence rates and favorable prostate-specific antigen (PSA) response were observed in men with nmCRPC who were treated with apalutamide.